Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are commonly used in the treatment of advanced non-small cell lung cancer. However, patients will inevitably develop resistance to EGFR-TKIs in the long-term treatment process. In this paper, we report a case of small cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoli, Li, Dongmei, Miao, Kun, Shou, Tao, Zhang, Wenjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875995/
https://www.ncbi.nlm.nih.gov/pubmed/36705363
http://dx.doi.org/10.1097/MD.0000000000032697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875995/
https://www.ncbi.nlm.nih.gov/pubmed/36705363
http://dx.doi.org/10.1097/MD.0000000000032697

Ejemplares similares